May 2023

Disclaimer: This page is intended only for persons who reside within India and should not be accessed, or relied upon by individuals residing outside India. The health information contained herein is provided for awareness purposes only, and is not intended to act as a diagnostic tool or to substitute in any manner, the need to seek prompt medical advice from a qualified healthcare professional. All decisions regarding a person’s diagnosis, treatment and care must be made after consultation with a healthcare provider, considering the unique characteristics of the person. While due care and caution has been taken to ensure that the content of this page is free from mistakes or omissions, Pfizer makes no representations or warranties of any kind, expressed or implied; as to the accuracy, completeness or adequacy of the contents on this page and will not be liable for any damages, adverse events, and personal liability arising therefrom.

Monthly Archives: May 2023

Telemedicine: Changing the Management of Chronic Pain

Opioid Denials Lead to Rise in Violent Attacks on Pain and Addiction Experts

FDA Clears Prescription Virtual Reality Therapeutic for Chronic Low Back Pain

Telemedicine: Changing the Management of Chronic Pain

ASA Responds to the Updated CDC Clinical Practice Guidelines for Prescribing Opioids

Virtually Administered PHQ-2 and GAD-2 Consistent, Accurate for Chronic Pain

It’s a Doctor’s Duty to Combat Misinformation

How Effective Are Interventions Targeting Depression in Chronic Pain?

A Closer Look at In-Home Administration of Ketamine

Combine and Conquer: A Treatment Strategy to Combat Drug-Use Associated Infections